Prasugrel in critically ill patients

While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Thromb Haemost
Auteurs principaux: Schoergenhofer, Christian, Hobl, Eva-Luise, Staudinger, Thomas, Speidl, Walter S., Heinz, Gottfried, Siller-Matula, Jolanta, Zauner, Christian, Reiter, Birgit, Kubica, Jacek, Jilma, Bernd
Format: Artigo
Langue:Inglês
Publié: Schattauer GmbH 2017
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/
https://ncbi.nlm.nih.gov/pubmed/28692105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires